Aspects of the Combined Use of Anticoagulant and Hemostatic Drugs in Large Joint Endoprosthetics
https://doi.org/10.33647/2074-5982-20-3-125-129
Abstract
The article presents a brief overview of the modern view on the problem of the combined use of drugs with a multidirectional spectrum of action, anticoagulants and hemostatics, in major orthopedics among patients with endoprosthetics of large joints of the lower extremities. Variable prescription regimens of anticoagulant prophylaxis against the background of using hemostatic drugs were analyzed.
About the Authors
L. S. Golovko
Regional Clinical Hospital No. 2 of the Ministry of Health Care of Rostov Region
Russian Federation
Russian Federation
Lilia S. Golovko, Cand. Sci. (Med.)
A. V. Safronenko
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Andrey V. Safronenko, Dr. Sci. (Med.), Prof.
E. V. Gantsgorn
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Elena V. Gantsgorn*, Cand. Sci. (Med.), Assoc. Prof.
M. Wehbh
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Mhammad Wehbh
I. M. Malleev
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Ibragim M. Malleev
A. A. Baloyan
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Artur A. Baloyan
R. M. Manvelyan
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Roland M. Manvelyan
E. V. Rashkova
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Ekaterina V. Rashkova
References
1. Bozhkova S.A., Kasimova A.R., Nakopia V.B., Kornilov N.N. Vse li my znaem o profilaktike venoznykh tromboembolicheskikh oslozhneniy posle bol'shikh ortopedicheskikh operatsiy? [Do we know all about prevention of venous thromboembolism after major orthopedic surgery?]. Traumatology and Orthopedics of Russia. 2018;24(1):129–143. (In Russian)]. DOI: 10.21823/2311-2905-2018-24-1-129-143.
2. Zhirova T.A., Lykov M.S., Zyryanov M.N., Babushkin V.N. Novye peroral'nye antikoagulyanty v strukture tromboprofilaktiki na fone rutinnogo ispol'zovaniya traneksamovoy kisloty pri endoprotezirovanii tazobedrennogo sustava [New oral anticoagulants for thromboprophylaxis routine use of tranexamic acid after hip joint replacement]. Anesthesiology and Reanimatology. 2014;59(6):34–38. (In Russian)].
3. Lebed M.L., Kirpichenko M.G., Shamburova A.S., Sandakova I.N., Bocharova Yu.S., Popova V.S., Karmanova M.M., Fesenko M.A., Golub I.E.. Sootnoshenie naruzhnoy i raschetnoy krovopoteri pri endoprotezirovanii krupnykh sustavov nizhney konechnosti [The ratio of external and calculated blood loss in arthroplasty of large joints of the lower extremity]. Polytrauma. 2020;2:29–35. (In Russian)]. DOI: 10.24411/1819-1495-2020-10017
4. Clavé A., Gérard R., Lacroix J., Baynat C., Danguy des Déserts M., Gatineau F., Mottier D. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty. Bone Joint J. 2019;101-B(2):207–212. DOI: 10.1302/0301-620X.101B2.BJJ-2018-0898.R1
5. Fraval A., Duncan S., Murray T., Duggan J., Tirosh O., Tran P. OBTAIN E: Outcome benefits of tranexamic acid in hip arthroplasty with enoxaparin: A randomised double-blinded controlled trial. HIP International. 2019;29(3):239–244. DOI: 10.1177/1120700018780125
6. Golovko L.S., Safronenko A.V., Gantsgorn E.V., Sukhorukova N.V., Kapliev A.V. Development of a risk-oriented algorithm for the combined use of hemostatics and anticoagulants to prevent thrombosis and bleeding cases after total arthroplasty of knee or hip joints. Research Results in Pharmacology. 2021;7(1):65–74. DOI: 10.3897/rrpharmacology.7.65708
7. Hourlier H., Fennema P. Tranexamic acid use and risk of thrombosis in regular users of antithrombotics undergoing primary total knee arthroplasty: A prospective cohort study. Blood Transfus. 2018;16(1):44–52. DOI: 10.2450/2016.0160-16
8. Zhou L.B., Wang C.C., Zhang L.T., Wu T., Zhang G.Q. Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: A prospective randomized study. BMC Musculoskelet Disord. 2023;24(1):5. DOI: 10.1186/s12891-022-06117-8
Review
For citations:
Golovko L.S., Safronenko A.V., Gantsgorn E.V., Wehbh M., Malleev I.M., Baloyan A.A., Manvelyan R.M., Rashkova E.V. Aspects of the Combined Use of Anticoagulant and Hemostatic Drugs in Large Joint Endoprosthetics. Journal Biomed. 2024;20(3):125-129. (In Russ.) https://doi.org/10.33647/2074-5982-20-3-125-129
Views:
143
Email this article 
